Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tami L Mark

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
Journal of Clinical Psychopharmacology|November 14, 2009
Health and economic burden of metabolic comorbidity among individuals with bipolar disorderFranca Centorrino, Tami L Mark, Alessandra Talamo, et al.
Psychiatric Services (Washington, D.C.)|September 29, 2020
How to Mitigate the Mental Health Care Consequences of the COVID-19 Financial CrisisAlison Cuellar, Tami L Mark, Steven S Sharfstein, et al.
Addiction (Abingdon, England)|May 25, 2021
The association of Medicare Part D prior authorization for buprenorphine-naloxone with adherence to opioid use disorder treatment guidelines in the United StatesWilliam J Parish, Tami L Mark, Gary A Zarkin, et al.
Journal of Studies on Alcohol and Drugs|April 7, 2021
Prior Authorization for Opioid Use Disorder Versus Pain Medications: Lessons Learned for Parity EnforcementTami L Mark, William J Parish, Ellen M Weber, et al.
Journal of Studies on Alcohol and Drugs|December 3, 2019
Increasing Access to Opioid Use Disorder Treatment: Assessing State Policies and the Evidence Behind ThemJesse M Hinde, Tami L Mark, Laurel Fuller, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2016
Prescriptions Filled Following an Opioid-Related HospitalizationSarah Naeger, Mir M Ali, Ryan Mutter, et al.
Journal of Substance Abuse Treatment|July 5, 2022
Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorderWilliam N Dowd, Daniel H Barch, Julie H Seibert, et al.
Journal of Occupational and Environmental Medicine|April 30, 2002
The business case for quality mental health services: why employers should care about the mental health and well-being of their employeesRon Z Goetzel, Ronald J Ozminkowski, Lloyd I Sederer, et al.
American Journal of Preventive Medicine|March 25, 2022
Substance Use Disorders Among Medicare Beneficiaries: Prevalence, Mental and Physical Comorbidities, and Treatment BarriersWilliam J Parish, Tami L Mark, Ellen M Weber, et al.
The American Journal of Managed Care|September 12, 2006
The effects of prescription drug copayments on statin adherenceTeresa B Gibson, Tami L Mark, Kimberly A McGuigan, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Journal of Clinical Psychopharmacology|November 14, 2009
Health and economic burden of metabolic comorbidity among individuals with bipolar disorderFranca Centorrino, Tami L Mark, Alessandra Talamo, et al.
Psychiatric Services (Washington, D.C.)|September 29, 2020
How to Mitigate the Mental Health Care Consequences of the COVID-19 Financial CrisisAlison Cuellar, Tami L Mark, Steven S Sharfstein, et al.
Addiction (Abingdon, England)|May 25, 2021
The association of Medicare Part D prior authorization for buprenorphine-naloxone with adherence to opioid use disorder treatment guidelines in the United StatesWilliam J Parish, Tami L Mark, Gary A Zarkin, et al.
Journal of Studies on Alcohol and Drugs|April 7, 2021
Prior Authorization for Opioid Use Disorder Versus Pain Medications: Lessons Learned for Parity EnforcementTami L Mark, William J Parish, Ellen M Weber, et al.
Journal of Studies on Alcohol and Drugs|December 3, 2019
Increasing Access to Opioid Use Disorder Treatment: Assessing State Policies and the Evidence Behind ThemJesse M Hinde, Tami L Mark, Laurel Fuller, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2016
Prescriptions Filled Following an Opioid-Related HospitalizationSarah Naeger, Mir M Ali, Ryan Mutter, et al.
Journal of Substance Abuse Treatment|July 5, 2022
Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorderWilliam N Dowd, Daniel H Barch, Julie H Seibert, et al.
Journal of Occupational and Environmental Medicine|April 30, 2002
The business case for quality mental health services: why employers should care about the mental health and well-being of their employeesRon Z Goetzel, Ronald J Ozminkowski, Lloyd I Sederer, et al.
American Journal of Preventive Medicine|March 25, 2022
Substance Use Disorders Among Medicare Beneficiaries: Prevalence, Mental and Physical Comorbidities, and Treatment BarriersWilliam J Parish, Tami L Mark, Ellen M Weber, et al.
The American Journal of Managed Care|September 12, 2006
The effects of prescription drug copayments on statin adherenceTeresa B Gibson, Tami L Mark, Kimberly A McGuigan, et al.
Pageof 13